{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:22:01Z","timestamp":1768285321960,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cases Journal"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1757-1626-2-9145","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T19:13:46Z","timestamp":1259954026000},"source":"Crossref","is-referenced-by-count":8,"title":["Treatment of metastatic urachal adenocarcinoma in a young woman: a case report"],"prefix":"10.1186","volume":"2","author":[{"given":"Elmehdi","family":"Tazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"Lalya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Fadl","family":"Tazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youness","family":"Ahallal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"M'Rabti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/cncr.22059","volume":"107","author":"JL Wright","year":"2006","unstructured":"Wright JL, Porter MP, Li CI, Lange PH, Lin DW: Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer. 2006, 107: 721-728. 10.1002\/cncr.22059.","journal-title":"Cancer"},{"key":"1350_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)50167-6","volume":"131","author":"CA Sheldon","year":"1984","unstructured":"Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE: Malignant urachal lesions. J Urol. 1984, 131: 1-8.","journal-title":"J Urol"},{"key":"1350_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1586\/14737140.6.12.1715","volume":"6","author":"A Siefker-Radtke","year":"2006","unstructured":"Siefker-Radtke A: Urachal carcinoma: surgical and chemotherapeutic options. Expert Rev Anticancer Ther. 2006, 6: 1715-1721. 10.1586\/14737140.6.12.1715.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1350_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/cncr.22060","volume":"107","author":"RA Ashley","year":"2006","unstructured":"Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H: Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer. 2006, 107: 712-720. 10.1002\/cncr.22060.","journal-title":"Cancer"},{"key":"1350_CR5","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/S0022-5347(06)00263-1","volume":"175","author":"JH Pinthus","year":"2006","unstructured":"Pinthus JH, Haddad R, Trachtenberg J, Holowaty E, Bowler J, Herzenberg AM, Jewett M, Fleshner NE: Population based survival data on urachal tumors. J Urol. 2006, 175: 2042-2047. 10.1016\/S0022-5347(06)00263-1.","journal-title":"J Urol"},{"key":"1350_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/01.ju.0000054646.49381.01","volume":"169","author":"AO Siefker-Radtke","year":"2003","unstructured":"Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL: Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience. J Urol. 2003, 169: 1295-1298. 10.1097\/01.ju.0000054646.49381.01.","journal-title":"J Urol"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.juro.2007.03.022","volume":"178","author":"HW Herr","year":"1997","unstructured":"Herr HW, Bochner BH, Sharp D, Dalbagni G, Reuter VE: Urachal carcinoma: contemporary surgical outcomes. J Urol. 1997, 178: 74-78. 10.1016\/j.juro.2007.03.022.","journal-title":"J Urol"},{"key":"1350_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-5347(17)34950-9","volume":"151","author":"HW Herr","year":"1994","unstructured":"Herr HW: Urachal carcinoma: the case for extended partial cystectomy. J Urol. 1994, 151: 365-366.","journal-title":"J Urol"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0090-4295(01)01259-6","volume":"58","author":"S Kawakami","year":"2001","unstructured":"Kawakami S, Kageyama Y, Yonese J, Fukui I, Kitahara S, Arai G, Hyouchi N, Suzuki M, Masuda H, Hayashi T, Okuno T, Kihara K: Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival. Urology. 2001, 58: 462-10.1016\/S0090-4295(01)01259-6.","journal-title":"Urology"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0090-4295(85)90121-9","volume":"26","author":"CJ Logothetis","year":"1985","unstructured":"Logothetis CJ, Samuels ML, Ogden S: Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C. Urology. 1985, 26: 252-255. 10.1016\/0090-4295(85)90121-9.","journal-title":"Urology"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF02550547","volume":"30","author":"O Ichiyanagi","year":"1998","unstructured":"Ichiyanagi O, Sasagawa I, Suzuki Y, Iijima Y, Kubota Y, Nakada T, Arai S: Successful chemotherapy in a patient with recurrent carcinoma of the urachus. Int Urol Nephrol. 1998, 30: 569-573. 10.1007\/BF02550547.","journal-title":"Int Urol Nephrol"},{"key":"1350_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1464-410X.1987.tb04992.x","volume":"60","author":"PM Quilty","year":"1987","unstructured":"Quilty PM: Urachal carcinoma: a response to chemotherapy. Br J Urol. 1987, 60: 372-10.1111\/j.1464-410X.1987.tb04992.x.","journal-title":"Br J Urol"},{"key":"1350_CR13","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1200\/JCO.1993.11.11.2194","volume":"11","author":"ML Rothenberg","year":"1993","unstructured":"Rothenberg ML, et al: Phase I and pharmacokinetic trial of weekly CPT-11. J Clin Oncol. 1993, 11: 2194-2204.","journal-title":"J Clin Oncol"},{"key":"1350_CR14","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","volume":"23","author":"HI Hurwitz","year":"2005","unstructured":"Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F: Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol. 2005, 23: 3502-3508. 10.1200\/JCO.2005.10.017.","journal-title":"J Clin Oncol"},{"key":"1350_CR15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/annonc\/mdh473","volume":"15","author":"C Pozzo","year":"2004","unstructured":"Pozzo C, Barone C, Szanto J, Padi E, Peschel C, B\u00fckki J, Gorbunova V, Valvere V, Zaluski J, Biakhov M, Zuber E, Jacques C, Bugat R: Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study. Ann Oncol. 2004, 15: 1773-1781. 10.1093\/annonc\/mdh473.","journal-title":"Ann Oncol"},{"key":"1350_CR16","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1200\/JCO.2004.01.140","volume":"22","author":"O Bouche","year":"2004","unstructured":"Bouche O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Ars\u00e8ne D, Paitel JF, Gu\u00e9rin-Meyer V, Mitry E, Buecher B, Kaminsky MC, Seitz JF, Rougier P, Bedenne L, Milan C, F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive Group: Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803. J Clin Oncol. 2004, 22: 4319-4328. 10.1200\/JCO.2004.01.140.","journal-title":"J Clin Oncol"}],"container-title":["Cases Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-1626-2-9145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1757-1626-2-9145\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-1626-2-9145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T17:50:26Z","timestamp":1548179426000},"score":1,"resource":{"primary":{"URL":"https:\/\/casesjournal.biomedcentral.com\/articles\/10.1186\/1757-1626-2-9145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1186\/1757-1626-2-9145","relation":{},"ISSN":["1757-1626"],"issn-type":[{"value":"1757-1626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"9145"}}